Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jan 4;15(1):1.
doi: 10.1186/s40545-021-00401-z.

Polypharmacy and the occurrence of potential drug-drug interactions among geriatric patients at the outpatient pharmacy department of a regional hospital in Durban, South Africa

Adetola Olaniyi Bojuwoye  1 , Fatima Suleman  1 , Velisha Ann Perumal-Pillay  2
Affiliations

Polypharmacy and the occurrence of potential drug-drug interactions among geriatric patients at the outpatient pharmacy department of a regional hospital in Durban, South Africa

Adetola Olaniyi Bojuwoye et al. J Pharm Policy Pract. .

Abstract

Background: Polypharmacy is the administration of an excessive number of medicines and a significant irrational medicine use practice. Little is known about this practice in South Africa. This study aimed to determine the level of polypharmacy and potential drug-drug interactions amongst the geriatric patient population in a facility in South Africa.

Method: A cross-sectional retrospective prescription chart review for 250 geriatric patients was conducted at the outpatient pharmacy department of a regional hospital. Variables extracted included demographic information, diagnosis, type of prescriber contact, and polypharmacy. Potential drug-drug interactions were determined with web-based multi-drug interaction checkers.

Results: The average (SD) number of diagnosed clinical problems was 3.54 ± 1.26, with hypertension, diabetes mellitus, and heart disease occurring most frequently. The level of polypharmacy was high with patients receiving an average (SD) of 12.13 ± 4.25 prescribed medicines from 3032 prescribed medicines. The level of polypharmacy was highest within the age categories, 60-64, and 70-74 years of age, respectively. The level of potential drug-drug interactions was also high with an average (SD) of 10.30 ± 7.48 from 2570 potential drug interactions. The majority of these interactions were moderate (72.5%) and pharmacodynamic (73.2%) by nature of the clinical severity of action and mechanism of action, respectively. Polypharmacy and type of prescriber contact were statistically significant contributors to the occurrence of potential drug-drug interactions, (F (2, 249) = 68.057, p < 0.05). However, in a multivariate analysis of variables to determine the strength of the association, polypharmacy was determined to be the strongest contributor to the occurrence of potential drug-drug interactions (p < 0.05) when compared with the type of prescriber contact (p value = 0.467). Therefore, irrespective of the type of prescriber contact, polypharmacy increases the potential for drug interactions among the sampled patient population.

Conclusion: A comprehensive consideration of disease management guidelines, patient factors, and rational medicine review could be measurable strategies towards improving medicine use. This would also limit the occurrence of significant drug interactions among the geriatric patient population. A national study is required to determine if differences occur across hospitals and regions.

Keywords: Drug interactions; Geriatric; Polypharmacy; South Africa.

PubMed Disclaimer

Conflict of interest statement

The authors declare that there are no competing interests.

Figures

Fig. 1
Fig. 1
Prescribed medicines by pharmaceutical formulation
Fig. 2
Fig. 2
Prescribed oral tablet formulations and the number of involvements in PDDIs
See this image and copyright information in PMC

References

    1. WHO. WHO | Medicines and health products. WHO. https://www.who.int/activities/promoting-rational-use-of-medicines (2019) Accessed 25 Dec 2019.
    1. Ofori-Asenso R, Agyeman AA. Irrational use of medicines-a summary of key concepts. Pharm (Basel, Switzerland). 2016;4(4):35. - PMC - PubMed
    1. WHO How to investigate drug use in health facilities. Select Drug Use Indic. 1993;7:92.
    1. Milton JC, Hill-Smith I, Jackson SHD. Prescribing for older people. BMJ. 2008;336(7644):606–609. doi: 10.1136/bmj.39503.424653.80. - DOI - PMC - PubMed
    1. Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm. 1990;47(3):533–543. - PubMed

LinkOut - more resources